Quipt Home Medical Corp. Files Definitive Proxy Statement

TL;DR

Quipt Home Medical Corp. DEF 14A filed. Get ready to vote on March 17, 2025.

AI Summary

Quipt Home Medical Corp. filed its definitive proxy statement (DEF 14A) on January 24, 2025, for its annual meeting on March 17, 2025. The filing details information related to the company's governance, executive compensation, and proposals to be voted on by shareholders. It also notes the company's former names, Protech Home Medical Corp. and Patient Home Monitoring Corp.

Why It Matters

This filing provides shareholders with crucial information needed to make informed voting decisions on company matters, including director elections and executive compensation.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders and does not inherently introduce new financial risks.

Key Numbers

• 20250124 — Filing Date (The date the definitive proxy statement was filed with the SEC.)
• 20250317 — Meeting Date (The date of the shareholder meeting for which this proxy statement is issued.)

Key Players & Entities

• Quipt Home Medical Corp. (company) — Registrant
• Protech Home Medical Corp. (company) — Former Company Name
• Patient Home Monitoring Corp. (company) — Former Company Name
• 0001558370-25-000412 (filing_id) — Accession Number

FAQ

Filing Documents

• qipt-20250317xdef14a.htm (DEF 14A) — 486KB
• qipt-20250317xdef14a_bg001.jpg (GRAPHIC) — 174KB
• qipt-20250317xdef14a_bg002.jpg (GRAPHIC) — 123KB
• 0001558370-25-000412.txt ( ) — 890KB

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management The following table presents information as to the beneficial ownership of our Common Shares as of January 16, 2025, for: (1) each shareholder known by us to be the beneficial owner of more than 5% of our Common Shares based solely on our review of the statement of beneficial ownership filed by 3 Table of Contents these persons/entities with the SEC; (2) each of our current directors or nominees for director; (3) each Named Executive Officer; and (4) all directors and executive officers as a group. None of these shares are pledged as security. The percentage of shares beneficially owned is based on 43,091,273 Common Shares outstanding as of January 16, 2025. Beneficial ownership is determined under the rules of the SEC and generally includes any shares over which a person exercises sole or shared voting or investment power. Unless otherwise indicated, the persons and entities named below have sole voting and sole investment power with respect to all shares beneficially owned, subject to community property laws where applicable. Unless otherwise indicated, the address for each listed stockholder is c/o Quipt Home Medical Corp., 1019 Town Drive, Wilder, Kentucky 41076. Name of Beneficial Owner Amount and Nature of Beneficial Ownership (1) Percent of Common Shares Outstanding (2) Named Executive Officers Gregory Crawford 3,703,278 (3) 8.4% Hardik Mehta 944,198 (4) 2.2% Thomas Roehrig 175,125 (5) * Non-Employee Directors Mark Greenberg 782,440 (6) 1.8% Kevin Carter 148,125 (7) * Brian Wessel 173,875 (8) * All directors and executive officers as a group (9 persons) 6,039,294 13.4% 5% Shareholders Forager Fund, L.P. 2025 3 rd Avenue North, Suite 350 Birmingham, AL 35203 4,199,562 (9) 9.7% Claret Asset Management Corporation 900 de Maisonneuve O., Suite 1900 Montreal, Quebec, Canada H3A 0A8 4,310,318 (10) 10.0% Kanen Wealth Management LLC 6810 Lyons T

View Full Filing

View this DEF 14A filing on SEC EDGAR